newsfilter
← Latest News
GlobeNewswire·

Landos Biopharma Announces Appointment of Fabio Cataldi, MD, as Chief Medical Officer

NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ:LABP), a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, today announced the appointment of Fabio Cataldi, MD,